PPT-XOSPATA TM (gilteritinib)

monotherapy for the treatment of relapsed or refractory acute myeloid leukaemia AML with a FLT3 mutation 1 XOS20200016IL Date of preparation Nov2020 1 MOH approved

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/918116" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "XOSPATA TM (gilteritinib)" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

XOSPATA TM (gilteritinib): Transcript

PPT-XOSPATA TM (gilteritinib)

Presentation Embed Code

Download Presentation

XOSPATA TM (gilteritinib): Transcript

Related Contents